kentucky glp-1 bowel obstruction law firm semaglutide gastric intestinal in Is Ileus Caused by Semaglutide-Containing Drugs Treatable? Kentucky: Justify compounded GLP-1s

Description

PlexusDx helps you navigate medication combinations through genetic insights and physician-guided treatment plans

### Funding Statement SDL and AC were supported by the National Science Foundation (Grant Nos.\ CAREER DMS-1944574 and DMS-2325258) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained

Type 2 Diabetes Mellitus (T2DM) is one of the most common metabolic disorders worldwide

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

Cigna will stop covering GLP-1 weight-loss drugs such as Wegovy and Zepbound for its employees starting July 1, signaling that even major healthcare companies are struggling with the high cost of these medications